This paper is in the following e-collection/theme issue:

Clinical Cancer Research (88) Innovations and Technology in Cancer Care (431) Cancer Survivorship (262) Participatory Cancer Care (89)

Published on in Vol 8, No 1 (2022): Jan-Mar

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31255, first published .
The Use of Telemedicine in Cancer Clinical Trials: Connect-Patient-to-Doctor Prospective Study

The Use of Telemedicine in Cancer Clinical Trials: Connect-Patient-to-Doctor Prospective Study

The Use of Telemedicine in Cancer Clinical Trials: Connect-Patient-to-Doctor Prospective Study

Authors of this article:

Yasmine Meghiref1 Author Orcid Image ;   Charles Parnot2 Author Orcid Image ;   Claire Duverger1 Author Orcid Image ;   Françoise Lilly Difoum1 Author Orcid Image ;   Audrey Gourden1 Author Orcid Image ;   Halima Yssaad1 Author Orcid Image ;   Caroline Leiterer1 Author Orcid Image ;   Caroline Bedekovic1 Author Orcid Image ;   Julien Blanchard1 Author Orcid Image ;   Houria Nait Ammar1 Author Orcid Image ;   Antoine Schernberg1 Author Orcid Image ;   Hélène Vanquaethem1 Author Orcid Image ;   Carole Helissey1 Author Orcid Image
Article Authors Cited by (11) Tweetations (4) Metrics

Journals

  1. Rivière C, Brureau L, Parnot C, Becherirat S, Duverger C, Picchi H, Le Roy A, Vuagnat P, Schernberg A, Vanquaethem H, Helissey C. Effectiveness of a digital telemonitoring platform for cancer care of older patients: The ConnectElderlyPatientToDoctor study. International Journal of Cancer 2023;152(3):504 View
  2. Helissey C, Parnot C, Rivière C, Duverger C, Schernberg A, Becherirat S, Picchi H, Le Roy A, Vuagnat P, Pristavu R, Vanquaethem H, Brureau L. Effectiveness of electronic patient reporting outcomes, by a digital telemonitoring platform, for prostate cancer care: the Protecty study. Frontiers in Digital Health 2023;5 View
  3. Franzoi M, Gillanders E, Vaz-Luis I. Unlocking digitally enabled research in oncology: the time is now. ESMO Open 2023;8(5):101633 View
  4. Chen D, Worden F, Haymart M. Access Denied: Disparities in Thyroid Cancer Clinical Trials. Journal of the Endocrine Society 2023;7(6) View
  5. Nindra U, Shivasabesan G, Childs S, Yoon R, Haider S, Hong M, Cooper A, Roohullah A, Wilkinson K, Pal A, Chua W. Time toxicity associated with early phase clinical trial participation. ESMO Open 2023;8(6):102046 View
  6. von Itzstein M, Gwin M, Gupta A, Gerber D. Telemedicine and Cancer Clinical Research. The Cancer Journal 2024;30(1):22 View
  7. Kastrisiou M, Karimi M, Christou E, Bizot A, Ropers M, De-Jesus A, Mokdad-Adi M, To T, Viansone A, Delaloge S, Besse B, Kfoury M. Evaluation of the satisfaction and experiences of oncology patients and doctors using teleconsultation during the COVID-19 pandemic. Journal of Telemedicine and Telecare 2024 View
  8. Urretavizcaya M, Álvarez K, Olariaga O, Tames M, Asensio A, Cajaraville G, Riestra A. Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology. European Journal of Hospital Pharmacy 2024:ejhpharm-2023-004072 View
  9. Munhoz R, Sabesan S, Thota R, Merrill J, Hensold J. Revolutionizing Rural Oncology: Innovative Models and Global Perspectives. American Society of Clinical Oncology Educational Book 2024;44(3) View
  10. Mittal A, Moore S, Navani V, Jiang D, Stewart D, Liu G, Wheatley-Price P. What Is Ailing Oncology Clinical Trials? Can We Fix Them?. Current Oncology 2024;31(7):3738 View
  11. Beauchemin M, Ortega M, Santacroce S, Robles J, Ruiz J, Hall A, Kahn J, Fu C, Orjuela-Grimm M, Hillyer G, Solomon S, Pelletier W, Montiel-Esparza R, Blazin L, Kline C, Seif A, Aristizabal P, Winestone L, Velez M. Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report. JNCI Cancer Spectrum 2024;8(4) View